InsidersTradesSigma
Episurf Medical AB Stock: price and directors' dealings · Finland · FIN-FSA
Follow the Episurf Medical AB share price and the full management transaction log of the company, a listed equity based in Finland. Shares are quoted on FI FI, under the supervision of FIN-FSA. Operating in the Health Care sector, Episurf Medical AB has recorded 2 insider filings. Market capitalisation: €458.8m. The latest transaction was reported on 9 July 2026 (Sale). Among the most active insiders: Mofast AB (Publ). The full history is free.
2
Insider Decl.
0
Thresholds
€3,107
1 ops.
Buy Volume
€19,690
1 ops.
Sell Volume
38Σ signal
Fundamental score
Ranked 20,338 of 25,956 companies
31.8
score / 100
Value14
Quality50
FCF yld-14%
Earn yld-13%
EV/EBITDA·
ROE-28%
Gross mgn75%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 9 July 2026
Declarations2 total
3,200,000 shares@ SEK 0.06830.048% mcap100.0% of flowAktieFI:csv-bdf5ec2066f8161d6fe5
210,396 shares@ €0.0148100.0% of flowAktieFI:A003Z129-1
Ideal exit: 16 Feb 2027 (T+270)
2 of 2 declarations
About Episurf Medical AB
Episurf Medical AB is a company focused on developing medical solutions for treating cartilage lesions in the knee. It concentrates on innovative technologies to enhance patients' quality of life.